Related Experiment Videos
[Aryloxy- and arylthioalkylamine hypolipidemic agents]
Il Farmaco; Edizione Scientifica
|September 1, 1983
Summary
New hypolipidemic agents based on clofibrate and probucol metabolites were synthesized. While some compounds demonstrated promising antilipemic activity, they also exhibited significant acute toxicity, limiting their therapeutic potential.
Area of Science:
- Medicinal Chemistry
- Pharmacology
Context:
- Development of novel hypolipidemic agents is crucial for managing dyslipidemia.
- Existing therapies have limitations, necessitating exploration of new chemical entities.
Purpose:
- To synthesize and evaluate aryloxy and arylthioalkylamines as potential hypolipidemic agents.
- To investigate structure-activity relationships for antilipemic effects and toxicity.
Summary:
- Aryloxy and arylthioalkylamines, structurally related to clofibrate and a probucol metabolite, were prepared.
- Pharmacological screening revealed that some synthesized compounds possess notable antilipemic activity.
- However, a significant drawback was the observed high acute toxicity in these promising compounds.
Impact:
- Identified novel chemical scaffolds with potential for lipid-lowering drug discovery.
- Highlighted the critical need to balance efficacy with safety in hypolipidemic drug development.
- Findings guide future research towards safer and more effective antilipemic compounds.